AGL, Cochlear, WiseTech shares: Buy, hold, sell

Find out what brokers expect next for these ASX shares.

AGL Energy Ltd (ASX: AGL), Cochlear Ltd (ASX: COH), and WiseTech Global Ltd (ASX: WTC) shares have all slumped lower over the past month, likely due to macroeconomic headwinds, weaker energy prices, and shifts in investor sentiment.

Here's the latest out of the ASX 200 shares, and what brokers expect next.

Couple looking at their phone surprised, symbolising a bargain buy.

Image source: Getty Images

Brokers rate AGL shares as a SELL

AGL shares are down around 0.1% to $8.31 at the time of writing on Wednesday morning. The ASX energy shares are now down around 4% over the past month and 11% lower year to date.

Over the past month, AGL shares have come under pressure from softer wholesale electricity prices and government regulation changes have also added a layer of uncertainty.

Mild weather, higher renewable energy generation, and battery storage growth are pushing wholesale electricity prices lower and reducing high-price spikes.

At the same time, the government is trying to push for lower costs by introducing price caps and limiting price increases. This could put pressure on AGL's margins going forward.

Brokers are mostly bearish on the outlook for the power company going forward. Market Index data shows the majority of brokers have a sell rating on AGL shares, and the $9.70 average target price implies a downside of around 16%, at the time of writing.

Brokers rate Cochlear shares as a HOLD

Cochlear shares have also slipped further into the red on Wednesday morning. At the time of writing, the shares are down around 0.2% to $129.99 each. The shares are down 7% over the past month and 50% lower year to date.

The shares fell around 14% in late September after the company announced to the ASX that it had received a class action claim filed against it in the Supreme Court of Victoria. 

The claim is on behalf of persons who acquired interests in Cochlear shares between 15 August 2025 and 21 April 2026 (inclusive). It relates to Cochlear's forecast of underlying net profit for FY26. 

Cochlear said it denies the allegations set out in the claim and will be defending the proceedings. But the news rattled investor confidence, and the shares have continued falling ever since.

The update comes off the back of ongoing operational headwinds. Looking ahead to FY27, the ASX healthcare company expects low-single-digit constant currency revenue growth and an underlying net profit between $330 million and $350 million. 

According to Market Index data, the majority of brokers have a hold rating on Cochlear shares. The $126.24 average target price implies a downside of around 3% at the time of writing.

Brokers rate WiseTech shares as a BUY

WiseTech shares are also down on Wednesday morning. At the time of writing, the shares have fallen around 0.5% to $31.79 each. Over the past month, WiseTech shares have tumbled 12%, and they're also down 54% for the year to date.

There hasn't been any price-sensitive news from the company over the past month to explain the latest sell-off. 

But it's been well-documented that the business has been smashed by a combination of headwinds over the past few months. Including an overall investor rotation away from tech shares, a series of regulatory investigations, and governance concerns. 

The company's FY26 results announcement in August didn't help confidence either. On the surface, the earnings result was positive, and earnings were in line with analyst expectations. But its EBITDA figures came in short of market forecasts, and investors rushed to sell up.

But it looks like the experts are still confident that WiseTech shares can bounce back over the next year. Market Index data shows all brokers have a strong buy rating on the shares. The $58.07 target price implies an upside of around 82% at the time of writing.

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear and WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended Cochlear. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Man sitting in a plane seat works on his laptop.
Broker Notes

Qantas shares were just downgraded but I still rate them as a buy

I think the downgrade was wrong and see value in the airline's shares.

Read more »

Smiling miner.
Broker Notes

4 ASX mining shares with 90% to 155% upside ahead: experts

These ASX mining shares have outstanding price growth potential.

Read more »

A woman smiles at the outlook she sees through binoculars.
Broker Notes

3 ASX shares tipped by brokers to return 48% to 109% over the next 12 months

Find out which ASX share is forecast to climb the highest by this time next year.

Read more »

a water tap is turned on and showering out banknotes into the open hand of a woman below it.
Broker Notes

This ASX small cap could jump 262% over the next year, one analyst says

This water technology company is having a strong year.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face.
Broker Notes

Woolworths, NextDC, Telstra shares: Buy, sell, or hold?

Here’s what the experts tip for these three major ASX shares.

Read more »

Man and woman sitting at table with the man looking a bit puzzled at his laptop.
Broker Notes

Buy, hold, sell: Wisetech Global, Wesfarmers, CSL shares

Christopher Watt from Bell Potter explains his ratings on 3 ASX 200 sector heavyweights.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Broker Notes

3 buy-rated biotechnology companies, including one which could jump 400%

If you're looking for exposure to healthcare, these companies could be worth a look.

Read more »

a young boy dressed in a business suit and wearing thick black glasses peers straight ahead while sitting at a heavy wooden desk with an old-fashioned calculator and adding machine while holding a pen over a large ledger book.
Broker Notes

Is the Xero share price too cheap to ignore?

If the company's growth plans stack up, this share could be one to watch.

Read more »